A Double-Blind Trial of Intravenous Thyrotrophin-Releasing Hormone in the Treatment of Reactive Depression
- 1 September 1975
- journal article
- clinical trial
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 127 (3) , 227-230
- https://doi.org/10.1192/bjp.127.3.227
Abstract
Summary: In a double-blind trial 600μg. of thyrotrophin-releasing hormone (TRH) was compared with placebo given daily for four days to two groups of ten patients. There was no significant difference between the antidepressant effects of TRH and placebo.Keywords
This publication has 9 references indexed in Scilit:
- THYROTROPHIN-RELEASING HORMONE IN THE TREATMENT OF DEPRESSIONThe Lancet, 1974
- Affective State and Thyrotropin and Prolactin Responses After Repeated Injections of Thyrotropin-Releasing Hormone in Depressed PatientsAmerican Journal of Psychiatry, 1974
- A DOUBLE-BLIND CROSSOVER SEQUENTIAL TRIAL OF ORAL THYROTROPHIN-RELEASING HORMONE IN DEPRESSIONThe Lancet, 1974
- EFFECTS OF THYROTROPIN-RELEASING HORMONE IN DEPRESSION*1The Lancet, 1972
- IMPROVEMENT IN MENTAL DEPRESSION WITH DECREASED THYROTROPIN RESPONSE AFTER ADMINISTRATION OF THYROTROPIN-RELEASING HORMONEThe Lancet, 1972
- Assessment of the severity of primary depressive illness: Wakefield self-assessment depression inventoryPsychological Medicine, 1971
- A Growing Edge of Measurement of Feelings [Abridged]Proceedings of the Royal Society of Medicine, 1969
- A Growing Edge of Measurement of Feelings [Abridged]Proceedings of the Royal Society of Medicine, 1969
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960